Currently, no country explicitly allows heritable human genome editing in clinical settings. It is not clear to what extent ...

One such breakthrough is the discovery of a potential ‘pause button’ for human embryos, which could revolutionise the way we ...

Researchers discovered that gene deserts, non-coding DNA regions, regulate heart and embryo development through enhancer ...

Legal scholar Dr. Joshua Weiser offers a framework for stem cell research in his book, "Embryonic Stem Cells and the Law." ...

Twist Bioscience focuses on synthetic DNA manufacturing, leveraging its proprietary silicon-based platform. Find out why I'm ...

The Human Genome Project should receive partial credit for giving us the technological advancement and innovation necessary ...

The results, described in The Lancet today, are impressive, says Kapil Bharti, a translational stem-cell researcher at the US ...

Fact checked by Karen Cilli If you’re hoping for a BFP after the TWW is finally over, you’re probably TTC. If that sentence ...

A ghostly white deep-sea shark, the first of its species with leucism, was caught at 656 feet off Sazan Island.

Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...

So the researchers used M-cells - human embryonic stem cell-derived mesenchymal stem cell-like cells. This type of cell had "gained attention as it possesses stronger immunomodulatory and ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.